Open-Label Trial of Atomoxetine to Evaluate Academic Outcome in Children Ages 8-11 Years With Attention Deficit/Hyperactivity Disorder
Clinical trial NCT00191880 · COMPLETED
Trial details
- NCT number
- NCT00191880
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.